Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lizza Hendriks

6PUBLICATIONS

12CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicinePredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 30, 2026

Retrospective Evaluation of the Use of Continuous Palliative Sedation and Continuous Opioid Infusion in Hospitalized Patients in End-Of-Life Care.

J L Gulikers, J Hamers, M van der Zande

|Dec 09, 2024

Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.

Judith Gulikers, Jeroen Bruinsma, Janna Schoenmaekers

|Jun 11, 2024

Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancer.

Judith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks

|Jun 13, 2023

Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD.

J L Gulikers, A J van Veelen, J H M Driessen

|Jun 09, 2023

Durvalumab after chemoradiotherapy in patients with stage III non-small-cell lung cancer: real-world outcomes versus clinical trial results.

Marjon V Verschueren, Talitha Dijs, Judith L Gulikers

|Mar 20, 2023

Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasma.

Judith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz

Pageof 1

Frequent Collaborators

2 joint publications

Lizza El Hendriks

1 joint publications

M Theunissen

1 joint publications

M H J van den Beuken-van Everdingen

1 joint publications

Marjon V Verschueren

1 joint publications

Ard van Veelen

1 joint publications

Lourens T Bloem

1 joint publications

Antoine Cg Egberts

1 joint publications

Ewoudt Mw van de Garde

1 joint publications

Bas Jm Peters

1 joint publications

Leila-Sophie Otten

Frequent Collaborators

2 joint publications

Lizza El Hendriks

1 joint publications

M Theunissen

1 joint publications

M H J van den Beuken-van Everdingen

1 joint publications

Marjon V Verschueren

Top Related Videos

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

Published on : Jul 04, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

See more related videos

Top Related Videos

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex

Published on : Jul 04, 2018

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on : May 27, 2021

See more related videos